下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEATN-224Cat. No.: HY-16074CAS No.: 649749-10-0Synonyms: Bis(choline)tetrathiomolybdate分式: CHMoNOS分量: 432.56作靶点: Others作通路: Others储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 47 mg/mL (108
2、.66 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 2.3118 mL 11.5591 mL 23.1182 mL5 mM 0.4624 mL 2.3118 mL 4.6236 mL10 mM 0.2312 mL 1.1559 mL 2.3118 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL ACTIVITY物活性 ATN-224种Cu2+/Zn2+-超氧化物歧化酶 1 (SOD1)
3、抑制剂。ATN-224 作内细胞,抑制抑制SOD1活性,IC50 为 17.53.7 nM。IC50 & Target IC50: 17.53.7 nM (SOD1, in endothelial cells) 11/3 Master of Small Molecules 您边的抑制剂师www.MedChemE体外研究 ATN-224 has a specific and high affinity for copper ions (108 mol/L-1) and shows no binding to calcium, iron,magnesium, zinc, or manganese
4、ions at concentrations up to 1 mM as determined by isothermal titrationcalorimetry. ATN-224 inhibits the proliferation of both HUVEC (IC50=1.40.3 M; n=5). ATN-224 is also ableto inhibit the activity of purified bovine SOD1 with an IC50 of 0.330.03 M after 24 hours of incubation. TheSOD1 inhibition b
5、y ATN-224 is time dependent, reaching maximal inhibition at 16 hours. ATN-224 seems toinhibit SOD1 by depleting the enzyme of copper. ATN-224 is able to inhibit SOD1 activity in endothelial cells,an effect that is dose dependent with an IC50 of 17.53.7 nM. ATN-224 inhibits FGF-2-induced ERK1/2phosph
6、orylation in a dose-dependent and time-dependent manner with an IC50 between 1.25 and 2.5 M,consistent with the IC50 for the inhibition of proliferation 1. ATN-224 is an orally-available inorganic smallmolecule that inhibits the copper/zinc-dependent enzyme, superoxide dismutase 1 (Cu/Zn-SOD1), inen
7、dothelial and tumor cells 2.体内研究 ATN-224 also significantly (P 1.PROTOCOLKinase Assay 1 Cells are plated in a six-well format (100-300,000 per well) and incubated with ATN-224 at indicatedconcentrations and for indicated times. Cells are then stimulated with 10 ng/mL FGF-2 for various times andlysed
8、. Lysates are subjected to Western blot analysis using an antibody specific for phosphorylated p44/42mitogen-activated protein kinase (Thr202/Tyr204) with appropriate signal correction using an antibodyspecific for p44/42 mitogen-activated protein kinase 1.MCE has not independently confirmed the acc
9、uracy of these methods. They are for reference only.Cell Assay 1 Human umbilical vein endothelial cells (HUVEC) are maintained in M200/LSGS medium and cells are usedbetween passages 2 and 4 for all experiments. For proliferation assay, cells are plated at 3,000 per well on0.1% gelatin in M200/2% FBS
10、 for 4 hours and then stimulated with 2 ng/mL FGF-2 in the presence orabsence of ATN-224 up to 48 hours. HUVEC proliferation is determined using either the Alamar Blue or theMTT assay. Multiple myeloma MM1S cells are grown in RPMI 1640 with 10% fetal bovine serum and 2 mML-glutamine. HL-60 promyeloc
11、ytic leukemia cells and MOLT-4 acute myeloblastic leukemia cells are plated at400,000/mL in T-75 flasks and incubated for 48 to 96 hours for proliferation assays. MMS1 cell proliferation isdetermined using calcein AM 1.MCE has not independently confirmed the accuracy of these methods. They are for r
12、eference only.Animal Mice 1Administration 1 Cold Matrigel (500 L) is mixed with 800 ng/mL FGF-2 or 300 ng/mL VEGF and heparin (50 g/mL).Negative control plugs did not contain the proangiogenic factors. The Matrigel mixture is injected s.c. into 4-to 8-week-old female BALB/c nude mice. In some experi
13、ments, either ATN-224 (94 M) with or without Mn-TBAP (100 M) or water is added directly to the Matrigel plug in the treated and negative control groups,respectively. Alternatively, mice are treated by oral gavage either with distilled water or ATN-224 everydayfrom Monday to Friday. Animals are sacri
14、ficed and the plugs are recovered 5 days after plug injection. Theplugs are then minced and homogenized with a tissue homogenizer, and hemoglobin levels in the plugs aredetermined using Drabkins solution.MCE has not independently confirmed the accuracy of these methods. They are for reference only.2
15、/3 Master of Small Molecules 您边的抑制剂师www.MedChemE户使本产品发表的科研献 Anal Chem. 2018 Jan 16;90(2):1317-1324.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Juarez JC, et al. Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition ofsuperoxide dismutase 1. Clin Cancer Res. 2006 Aug 15;12(16):4974-82.2. Lin J, et al. A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, inpatients with biochemically recurrent hormone-nave prostate can
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 污水处理厂初沉池改造方案
- 网络机房建设工程竣工验收报告
- 水库清淤扩容工程清淤设备配置方案
- 硫铁矿制酸项目焙烧系统方案
- 洁净生产车间继电器生产空间暖通空调系统优化设计
- 电子级金属粉体生产项目仓储管理方案
- 2026年排他性风险投资合同书
- 2026年互联网审计品牌合作合同
- 2026年长期网络安全评估合同
- 2026年度充电桩建设经销协议
- 《美食制作中的魅力化学》课件
- TSDSCA 0001-2024 人脐带组织来源的间充质干细胞制备与质量控制
- 2025年内蒙古呼道德与法制中考试卷和浩特
- 2025年江苏省苏州工业园区管委会招聘14人历年高频重点提升(共500题)附带答案详解
- (高清版)DB52∕T 1450-2019 河道管理范围划界技术规程
- 卫生化学(人卫第七版)考点全套
- 《财务管理学(第10版)》课件全套 王化成 第1-12章 总论、财务管理的价值观念-并购与重组
- 中国戏曲剧种鉴赏智慧树知到期末考试答案章节答案2024年上海戏剧学院等跨校共建
- 汽车维修工时收费标准(二类企业)
- 韶音供应商QSA+QPA审核-checklist-V1
- JGT483-2015 岩棉薄抹灰外墙外保温系统材料
评论
0/150
提交评论